Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-020-00903-0
Published Online: 2020-09-02
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilke, Thomas
Mueller, Sabrina
Fuchs, Andreas
Kaltoft, Margit S.
Kipper, Stefan
Cel, Malgorzata
Funding for this research was provided by:
Novo Nordisk Pharma GmbH
Text and Data Mining valid from 2020-09-02
Version of Record valid from 2020-09-02
Article History
Received: 13 May 2020
First Online: 2 September 2020